<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It has been shown in vitro that <z:chebi fb="0" ids="30316">dihydrolipoate</z:chebi> (DL-6,8-dithioloctanoic acid) has <z:chebi fb="11" ids="22586">antioxidant</z:chebi> activity against microsomal <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation </plain></SENT>
<SENT sid="1" pm="."><plain>We tested <z:chebi fb="0" ids="30316">dihydrolipoate</z:chebi> for its neuroprotective activity using models of hypoxic and excitotoxic neuronal damage in vitro and <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent models</z:e> of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in vivo </plain></SENT>
<SENT sid="2" pm="."><plain>In vitro, neuronal damage was induced in primary neuronal cultures derived form 7-day-old chick embryo telencephalon by adding either 1 mM <z:chebi fb="53" ids="17514">cyanide</z:chebi> or 1 mM <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> to the cultures </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="53" ids="17514">Cyanide</z:chebi>-exposed and <z:chebi fb="0" ids="30316">dihydrolipoate</z:chebi>-treated (10(-9)-10(-7) M) cultures showed an increased protein and ATP content compared with controls </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>-exposed cultures treated with <z:chebi fb="0" ids="30316">dihydrolipoate</z:chebi> (10(-7)-10(-5) M) showed a decreased number of damaged neurons </plain></SENT>
<SENT sid="5" pm="."><plain>In vivo, <z:chebi fb="0" ids="30316">dihydrolipoate</z:chebi> treatment (50 and 100 mg/kg) reduced <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> after permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in mice and rats </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="30316">Dihydrolipoate</z:chebi> treatment (50 and 100 mg/kg) could not ameliorate neuronal damage in the rat hippocampus or cortex caused by 10 min of forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>A comparable neuroprotection was obtained by using dimethylthiourea, both in vitro (10(-7) and 10(-6) M) and at a dose of 750 mg/kg in the focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> models </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="30313">Lipoate</z:chebi>, the oxidized form of <z:chebi fb="0" ids="30316">dihydrolipoate</z:chebi>, failed to reduce neuronal injury in any model tested </plain></SENT>
<SENT sid="9" pm="."><plain>We conclude that <z:chebi fb="0" ids="30316">dihydrolipoate</z:chebi>, similarly to dimethylthiourea, is able to protect neurons against ischemic damage by diminishing the accumulation of reactive oxygen species within the cerebral tissue </plain></SENT>
</text></document>